Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

In Vitro Priming Recapitulates In Vivo HIV-1 Specific T Cell Responses, Revealing Rapid Loss of Virus Reactive CD4+ T Cells in Acute HIV-1 Infection

  • Rachel Lubong Sabado,

    Affiliation New York University School of Medicine, New York, New York, United States of America

    ⨯
  • Daniel G. Kavanagh,

    Affiliation Partners AIDS Research Center (PARC), Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, United States of America

    ⨯
  • Daniel E. Kaufmann,

    Affiliation Partners AIDS Research Center (PARC), Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, United States of America

    ⨯
  • Karlhans Fru,

    Affiliation Molecular Virology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden

    ⨯
  • Ethan Babcock,

    Affiliation New York University School of Medicine, New York, New York, United States of America

    ⨯
  • Eric Rosenberg,

    Affiliation Partners AIDS Research Center (PARC), Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, United States of America

    ⨯
  • Bruce Walker,

    Affiliation Partners AIDS Research Center (PARC), Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, United States of America

    ⨯
  • Jeffrey Lifson,

    Affiliation SAIC Fredrick, Inc., National Cancer Institute, Fredrick, Frederick, Maryland, United States of America

    ⨯
  • Nina Bhardwaj,

    Affiliation New York University School of Medicine, New York, New York, United States of America

    ⨯
  • Marie Larsson

    marla@imk.liu.se

    Affiliation Molecular Virology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden

    ⨯

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.